MENU
MDGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Madrigal Pharmaceuticals (MDGL) Ownership - Who owns Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.43B
P/E Ratio
N/A
Total Cash
797.02M
Projected Growth
N/A
Total Debt
123.95M
Revenue
515.55M
Risk (Beta)
-1.94
Dividend Yield
N/A
Total Cash/Share
35.76
Total Debt/Equity
N/A
Revenue/Share
23.44 USD as % of share price
Fundamentals
MDGL
Capitalization
9.43B
P/E Ratio
N/A
Risk (Beta)
-1.94
Dividend Yield
N/A
Total Cash
797M
Total Cash/Share
35.76
Total Debt
124M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
23.44%
Revenue
516M
ROE
N/A
Book Value
696M
P/B Ratio
13.55
Cash Flow
N/A
Earnings
-12.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
5.11
Current Revenue Per Employee
403034.10
Dividends Per Share - Security
N/A
EBITDA
-266.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.74
Revenue To Assets
-26.66
Shares Held By Institutions
12B
Shares Outstanding - Current
22.3M
Total Liabilities
319M
Total Volume MTD
N/A
Value
N/A
Gain YTD
37.081
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDGL showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com